Jing Kan

3.8k total citations
61 papers, 1.1k citations indexed

About

Jing Kan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jing Kan has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 35 papers in Cardiology and Cardiovascular Medicine and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jing Kan's work include Coronary Interventions and Diagnostics (41 papers), Cardiac Imaging and Diagnostics (29 papers) and Acute Myocardial Infarction Research (15 papers). Jing Kan is often cited by papers focused on Coronary Interventions and Diagnostics (41 papers), Cardiac Imaging and Diagnostics (29 papers) and Acute Myocardial Infarction Research (15 papers). Jing Kan collaborates with scholars based in China, United States and Italy. Jing Kan's co-authors include Shao‐Liang Chen, Junjie Zhang, Fei Ye, Tak Kwan, Teguh Santoso, Zhen Ge, Nai‐Liang Tian, Zhou Yong, Qiang Fu and Yawei Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Jing Kan

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Kan China 14 861 697 646 325 32 61 1.1k
Yoshihisa Kanaji Japan 18 931 1.1× 841 1.2× 831 1.3× 270 0.8× 17 0.5× 147 1.2k
Tadashi Murai Japan 19 1.1k 1.3× 914 1.3× 998 1.5× 283 0.9× 25 0.8× 111 1.4k
Salem H.K. The Netherlands 14 652 0.8× 379 0.5× 429 0.7× 392 1.2× 49 1.5× 31 901
Stéphane Champagne France 16 389 0.5× 596 0.9× 489 0.8× 110 0.3× 40 1.3× 81 865
Hideo Takebayashi Japan 15 799 0.9× 454 0.7× 553 0.9× 362 1.1× 17 0.5× 27 896
Yngvar Myreng Norway 14 458 0.5× 564 0.8× 393 0.6× 147 0.5× 15 0.5× 22 768
Yusuke Tanino Japan 12 743 0.9× 361 0.5× 312 0.5× 355 1.1× 37 1.2× 16 922
Yusuke Fujino Japan 17 729 0.8× 375 0.5× 437 0.7× 381 1.2× 12 0.4× 59 865
Tetsuya Fusazaki Japan 12 416 0.5× 288 0.4× 284 0.4× 170 0.5× 11 0.3× 36 574
Takashi Muro Japan 15 259 0.3× 547 0.8× 426 0.7× 124 0.4× 54 1.7× 51 759

Countries citing papers authored by Jing Kan

Since Specialization
Citations

This map shows the geographic impact of Jing Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Kan more than expected).

Fields of papers citing papers by Jing Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Kan. The network helps show where Jing Kan may publish in the future.

Co-authorship network of co-authors of Jing Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Kan. A scholar is included among the top collaborators of Jing Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Kan. Jing Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Yongbum, Xiaofei Gao, Sang‐Hyup Lee, et al.. (2025). De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome. Annals of Internal Medicine. 178(4). 533–542. 1 indexed citations
2.
Kan, Jing, et al.. (2025). IMMUNE CHECKPOINT INHIBITOR ASSOCIATED TRIPLE M OVERLAP SYNDROME: A COMPLEX CASE OF MYOCARDITIS. Journal of the American College of Cardiology. 85(12). 3238–3238.
3.
Gao, Xiaofei, Jing Kan, Zhiming Wu, et al.. (2024). IVUS-Guided vs Angiography-Guided PCI in Patients With Diabetes With Acute Coronary Syndromes. JACC: Cardiovascular Interventions. 18(3). 283–293. 3 indexed citations
4.
Zhang, Hang, Jing Kan, Juan Zhang, et al.. (2023). 3-Year Outcome in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension. JACC Heart Failure. 11(8). 1135–1146. 8 indexed citations
5.
Lee, Seung‐Yul, Junjie Zhang, Gary S. Mintz, et al.. (2022). Procedural Characteristics of Intravascular Ultrasound–Guided Percutaneous Coronary Intervention and Their Clinical Implications. Journal of the American Heart Association. 11(14). e025258–e025258. 7 indexed citations
6.
Hong, Sung‐Jin, Junjie Zhang, Gary S. Mintz, et al.. (2022). Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation. JACC: Cardiovascular Interventions. 15(2). 208–216. 27 indexed citations
8.
Lee, Yong‐Joon, Junjie Zhang, Gary S. Mintz, et al.. (2021). Impact of Intravascular Ultrasound–Guided Optimal Stent Expansion on 3-Year Hard Clinical Outcomes. Circulation Cardiovascular Interventions. 14(10). e011124–e011124. 18 indexed citations
9.
Li, Xiaobo, Jing Kan, Liping She, et al.. (2020). Optical coherence tomography predictors of target vessel myocardial infarction after provisional stenting in patients with coronary bifurcation disease. Catheterization and Cardiovascular Interventions. 97(7). 1331–1340. 3 indexed citations
10.
Zhang, Rihua, Jing Kan, Shan Lü, et al.. (2019). S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Bioscience Reports. 39(9). 11 indexed citations
11.
Chen, Mengxuan, Jing Kan, Junjie Zhang, et al.. (2019). Improvement of clinical outcome in patients with ST‐elevation myocardial infarction between 1999 and 2016 in China: The Prospective, Multicentre Registry MOODY study. European Journal of Clinical Investigation. 50(2). e13197–e13197. 4 indexed citations
12.
Qian, Xuesong, Xiaofei Gao, Zhen Ge, et al.. (2018). Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention. Chinese Medical Journal. 131(9). 1023–1029. 9 indexed citations
14.
Kan, Jing, Zhen Ge, Junjie Zhang, et al.. (2016). Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers. JACC: Cardiovascular Interventions. 9(11). 1115–1123. 62 indexed citations
15.
Gao, Xiaofei, Junjie Zhang, Zhen Ge, et al.. (2016). Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention. Patient Preference and Adherence. 10. 871–871. 13 indexed citations
17.
Kan, Jing, Feng Chen, Liya Liu, et al.. (2013). Quantitative assessment of late lumen loss after biodegradable polymer and permanent polymer sirolimus-eluting stents implantation. Chinese Medical Journal. 126(6). 1081–1085. 2 indexed citations
18.
Ye, Fei, Junjie Zhang, Song Lin, et al.. (2010). The Acute Changes of Fractional Flow Reserve in DK (Double Kissing), Crush, and 1‐Stent Technique for True Bifurcation Lesions. Journal of Interventional Cardiology. 23(4). 341–345. 14 indexed citations
19.
Chen, Shao‐Liang, Fei Ye, Zhizhong Liu, et al.. (2010). Crush Stenting With Drug‐Eluting Stents: Relevance of Coronary Bifurcation Lesion Location on Angiographic and Clinical Outcomes. Clinical Cardiology. 33(12). E32–9. 4 indexed citations
20.
Chen, Shao‐Liang, Junjie Zhang, Fei Ye, et al.. (2009). Effect of coronary bifurcation angle on clinical outcomes in Chinese patients treated with crush stenting: a subgroup analysis from DKCRUSH-1 bifurcation study. Chinese Medical Journal. 122(4). 396–402. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026